Dasotraline Binge Eating Disorder Extension Study

PHASE3CompletedINTERVENTIONAL
Enrollment

533

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 24, 2019

Study Completion Date

June 24, 2019

Conditions
Binge Eating Disorder
Interventions
DRUG

Dasotraline

Dasotraline 4, 6, 8 mg flexibly dosed once daily

Trial Locations (57)

10036

Manhattan Behavioral Medicine, PLLC, New York

10128

The Medical Research Network, LLC, New York

10549

Bioscience Research, LLC, Mount Kisco

18104

Lehigh Center For Clinical Research, Allentown

20170

NeuroScience, Inc., Herndon

27612

Wake Research Associates, Raleigh

29464

Coastal Carolina Research Center, Mt. Pleasant

29621

Radiant Research, Inc., Anderson

29650

Radient Research, Inc., Greer

30005

Institute of Advanced Medical Research, Alpharetta

30060

Northwest Behavioral Research Center, Marietta

30342

Neuotrials Research, Inc., Atlanta

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

32801

Clinical Neuroscience Solutions, Inc., Orlando

33143

Miami Research Associates, South Miami

33161

Segal Institute for Clinical Research, North Miami

33912

Gulfcoast Clinical Research Center, Fort Myers

37203

Clinical Research Associates, Inc., Nashville

38119

Clinical Neuroscience Solutons, Inc., Memphis

44311

Radiant Research, Inc., Akron

45040

Lindner Center Of Hope, Mason

45215

Patient Priority Clinical Sites, Cincinnati

45417

Midwest Clinical Research Center, Dayton

46260

Goldpoint Clinical Research, Inc., Indianapolis

60048

Capstone Clinical Research, Libertyville

63304

St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles

66208

Phoenix Medical Research, Inc. Suite 135, Prairie Village

67226

Cyress Medical Research Center, LLC, Wichita

73103

IPS Research Company, Oklahoma City

75023

Psychiatric Medical Associates, Plano

77081

Texas Center for Drug Development, Inc., Houston

78229

Clinical Trials of Texas, Inc., San Antonio

Radient Research, Inc., San Antonio

78737

Donald J. Garcia Jr., MD, Austin

80910

MCB Clinical Research Centers, LLC, Colorado Springs

84123

Radiant Research, Inc., Murray

85032

Noesis Parma, Phoenix

90210

Southern California Research, Beverly Hills

91316

Pharmacology Research Institute, Encino

92078

Artemis Institute for Clinical Research, San Marcos

92660

Pharmacology Research Institute, Newport Beach

92705

Syrentis Clinical Research, Santa Ana

92845

Collaborative NeuroScience Network Inc., Garden Grove

97214

Oregon Center for Clinical Investigatons, INC., Portland

97301

Oregon Center for Clinical Investigations, Inc., Salem

97504

Sunstone Medical Research, LLC, Medford

98104

Summitt Research Network(Seattle) LLC, Seattle

80209*

Weiss and Lytle, PLLC, Denver

06416

CT Clinical Research, Cromwell

02478

McLean Hospital, Belmont

02131

Boston Clinical Trials, Boston

01844

ActivMed Practices & Research, Inc., Methuen

02472

Adams Clinical Trials, LLC, Watertown

03801

ActivMed Practices and Research, Inc., Portsmouth

08002

Center for Emotional Fitness, Cherry Hill

08540

Princeton Medical Institute, LCC, Princeton

05091

Neuropsychiatric Associates, Woodstock

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT02684279 - Dasotraline Binge Eating Disorder Extension Study | Biotech Hunter | Biotech Hunter